Skip to navigation | Skip to main content | Skip to footer
Search the University of Manchester siteSearch Menu StaffNet
Search type

Research beacons: The future of cancer treatment

15 Jul 2020

Our University’s critical role during the Covid-19 pandemic was visible in the numbers of staff and student who stepped forward to take up volunteering or supporting roles that contributed to the national response

Cancer futures

Now, as we emerge into this new post-crisis world, Covid-19’s effects on health and research systems globally are increasingly being felt, with cancer one such area where the full effects of the pandemic are starting to be realised.

Successfully addressing the impact of delayed diagnosis and treatment means that now more than ever it’s vital that the research community works together to drive research impact to the patient, as quickly as possible.

Such a collective research effort demands a multidisciplinary approach, ensuring a wide number of scientists with complementary expertise are working together within a team science approach to cancer research, given the scale of the problem; with cancer the second leading cause of death globally.

This multidisciplinary team approach is something that colleagues within our University have long been quietly revolutionising, as evidenced in a new publication, celebrating the successes of this approach in the cancer research community and highlighting how research breakthroughs by such an approach is helping to provide insight, innovation and impact where and when it is needed most.

Cancer Futures - Second edition contains a set of research stories which give a flavour of some of the work that our clinicians and scientists within the Faculty of Biology, Medicine and Health are leading, and whose brilliance lie in being the ability to draw upon the breadth of institutional research expertise to achieve research breakthroughs for all patients.  

Prof Rob Bristow, Director of the Cancer Domain, FBMH said: "With cancer recognised as one of the University’s five research beacons, and one of the reasons I chose to come to Manchester, it’s an opportunity for us to share and celebrate, just some of the brilliance in cancer research and discovery science that makes us a global cancer lead.

“Our academic community has established innovative and multidisciplinary ways of working to achieve better patient outcomes globally. These stories accentuate and celebrate just what we can achieve as a community and can inspire future academic collaborations across all disease types.

“As we continue to realise our scientific innovation as an international leading cancer centre, it’s important to share some of these stories, and the fantastic researchers behind them, that help shape our ambition to transform cancer care in a global manner and to show how our scientists are again at the frontline in the next phase of the pandemic response.”

More information: